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Abstract 28 
Ovarian hormones regulate the transcriptome of the hippocampus and modulate its functions. During 29 
menopause, this complex signaling declines, leading to impaired learning and memory. This study was 30 
undertaken to clarify the effects of long-term, surgical ovariectomy (OVX) on the rat hippocampal 31 
transcriptome. At age of 13 months, intact control and ovariectomized groups were formed. All animals 32 
were sacrificed 5 weeks after gonadectomy, hippocampal formations were dissected and processed for 33 
transcriptome analysis. Microarray and PCR studies identified 252 and 61 genes, respectively, whose 34 
expression was altered in the lack of ovarian hormones. Pathway analysis revealed impact on 35 
neuroactive ligand-receptor interaction, endocannabinoid and estrogen signaling, among others. 36 
Network and interaction analyses of proteins encoded by OVX-regulated genes revealed upregulation 37 
of growth/ troph/transcription factor signaling assembly (Mdk, Fgf1, Igf2, Ngf, Ngfr, Ntf3, Ntrk1, Otx2, 38 
Hif1a, Esr1, Nr4a3), peptides/peptide receptors (Cartp, Kl, Ttr, Gnrhr), neurotransmission (Grm1, 39 
Gria4, Gls, Slc18a2, Kcj6) and genes serving immune functions (C3, Ccl2, Itgam, Il1b). Downregulated 40 
clusters included neuropeptides and their receptors (Adcyap1, Cbln2, Cck, Cckbr, Crhr1 and 2, Oprd1, 41 
Nts, Penk, Sstr1, Vip), neurotransmitter signaling (Htr2c, Chrna3, Chrm4, Grm8, Hrh3, Slc17a6) and 42 
potassium channels (Kcnk9, Kcnj9, Kcnma1, Kcnc2). Several transcription factors (Rxra, Thrb), solute 43 
carriers and defense molecules (Apitd1, Bcl2, Clql3, Ilr3a, Sod1, Sncb) also underwent downregulation. 44 
The findings indicate that surgical gonadectomy carried out at middle-age robustly changes the 45 
hippocampal transcriptome that alters neurogenesis, synaptic plasticity, immune modulation causing 46 
cognitive dysfunctions. 47 
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Introduction 49 
The ovarian hormone supply is crucial for development of the brain and maintenance of its diverse 50 
functions (1-3). The proper physiological performance of the ovary is guaranteed and regulated by the 51 
hypothalamo-pituitary neuroendocrine unit (4). Aging results in a decrease in the production of ovarian 52 
hormones, including the gonadal sex steroids estradiol and progesterone (5,6). During menopause, the 53 
ovarian hormone supply to the brain, including the hippocampal formation, gradually weakens causing 54 
impairments in learning ability, memory processing and spatial navigation (7,8). These events 55 
negatively influence quality of life in menopause, therefore, various strategies of hormone replacement 56 
therapy (HRT) have been introduced (9,10).  Current efforts are aimed at HRTs with low health risk 57 
consequence and high effectiveness (11-13). The timing of HRT has been found crucial (14,15) in order 58 
to keep the brain’s responsiveness to ovarian hormones and prevent structural disintegration of the 59 
neural tissue. In experimental neuroscience, middle-aged, ovariectomized animals have been widely 60 
used as models of menopause including primates (16,17) and rodents (18-23). The beneficial role of 61 
HRT has been shown in counter-balancing hippocampus-related dysfunctions. These studies indicate 62 
that declining ovarian hormone signaling to the hippocampal formation promotes neuroinflammation 63 
(24), disturbs synaptic signaling and plasticity (25-29), alters neurogenesis (26,30,31) and decreases the 64 
efficacy of cellular neuroprotective mechanisms (32-34).  65 
Although many HRT studies used the ovariectomized animal model, the impact of surgical, long-term 66 
OVX per se upon the hippocampal transcriptome and functions has not been fully elucidated yet. We 67 
hypothesized that ablation of ovarian hormones by gonadectomy in middle-aged, female rats results in 68 
malfunction of the related hormone receptors leading to modification of gene expression and altered 69 
functions. Therefore, in this study, the hippocampal transcriptomes of intact control and long-term 70 
ovariectomized, middle-aged rats were compared using microarray and quantitative real-time PCR. The 71 
predicted networking of proteins encoded by OVX-regulated genes was also analyzed.  We identified 72 
clusters of differentially-regulated genes, indicating that gonadal hormone ablation might alter essential 73 
hippocampal functions.   74 
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Material and Methods 76 
Experimental animals 77 
All experiments were performed with permission from the Animal Welfare Committee of the Institute 78 
of Experimental Medicine (IEM, Permission Number: A5769-01) and in accordance with regulations of 79 
the European Community (Decree 86/609/EEC). Female Harlan-Wistar rats were purchased from 80 
Toxicoop (Budapest, Hungary) and housed on a 12h light/12h dark cycle in the animal care facility of 81 
IEM. The rats were used as breeders and retired at their age of 8 months, then housed individually for 82 
the subsequent months. At their age of 13 months, 14 animals were deeply anesthetized and sham-83 
operated or ovariectomized bilaterally (18,35). Two experimental animal groups were formed: intact 84 
control group (n=6) and ovariectomized group (n=8).  Both groups were kept on phytoestrogen-free diet 85 
(Harlan Teklad Global Diets, Madison, WI). Intact middle-aged female rats show the initial signs of 86 
reproductive aging manifested in persistent vaginal cornification, tonic estrogen secretion and low 87 
plasma levels of progesterone (36). Accordingly, our middle-aged intact females had low serum E2 level 88 
(12 pg/mL). In contrast, ovariectomized middle-aged animals had only residual serum E2 (2 pg/mL), 89 
significantly decreased uterus weight and significantly increased body weight indicating progressing 90 
reproductive senescence and clear signs of menopause. Five weeks after the surgical intervention all 91 
animals were terminated, the brains were quickly removed from the skull and placed into an ice-cold rat 92 
brain matrix. A three millimeter thick coronal slice was dissected with two blades positioned at bregma 93 
levels -3.8 and -6.8. Between these levels the targeted part of the hippocampal formation was easily 94 
separable from the neighboring brain areas (the thalamus and the corpus callosum), it was lifted from 95 
the slice and processed for transcriptome analysis. 96 
Affymetrix Rat Genome 230PM Strip Arrays 97 
Hippocampal formations from 14 animals were prepared and total RNA was isolated and analyzed as 98 
described previously (24). RNA quality was measured and samples displayed high RNA integrity 99 
numbers (RIN > 8.2) on Agilent’s Bioanalyzer Nano RNA chips (Santa Clara, CA, USA). Four samples 100 
from each group were individually examined by oligonucleotide microarray including amplification, 101 
target labeling, hybridization, staining and scanning steps, which were carried out as described earlier 102 
(26). In brief, using 25 ng of total RNA Whole Transcriptome Amplification (WTA) library preparation 103 
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and amplification for 17 cycles were performed following distributor's (Sigma-Aldrich) 104 
recommendations. 8 µg cDNA was fragmented by DNase I and biotinylated by terminal transferase 105 
obtained from the GeneChip Mapping 250K Nsp Assay Kit (Affymetrix Inc, Santa Clara, CA, USA). 106 
Hybridization, washing, staining and scanning of Affymetrix Rat Genome 230 PM Strip arrays were 107 
performed following the manufacturer’s recommendations. Scanned images (DAT files) were 108 
transformed into intensities (CEL files) using the AGCC software (Affymetrix).  109 
Quantitative real-time PCR 110 
Custom TaqMan microfluidic cards (Applied Biosystems, Foster City, CA, USA) were designed to 111 
study mRNA expression by real-time PCR. Fourteen samples were examined. Reverse transcription and 112 
PCR were carried out by using Applied Biosystems’ High Capacity cDNA Reverse Transcription Kit 113 
and TaqMan Universal PCR Master Mix II, respectively. PCR data evaluation were performed as 114 
described previously (24). The ViiA7 RUO 1.2.1 (Applied Biosystems) software and relative 115 
quantification against calibrator samples (Ct) were used for data evaluation. Intact control was the 116 
calibrator sample. Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and hypoxanthine guanine 117 
phosphoribosyl-transferase (Hprt) were used as housekeeping genes. Expression of these genes did not 118 
vary among experimental groups. A computed internal control corresponding to the geometric mean of 119 
cycle threshold (Ct) values of Gapdh and Hprt was used for ΔCt calculation. Relative quantity (RQ) 120 
was calculated according to RQ=2^(-ΔΔCt) equation. 121 
Data analysis 122 
Microarray data analysis, including GC robust multi-array average (GCRMA), statistical and data 123 
mining work, were carried out as published earlier (25,26). In brief, raw data were preprocessed for 124 
analysis using GCRMA. For selection of differentially expressed genes, fold change values were used 125 
and linear models combined with empirical Bayesian methods were applied. Obtained p-values were 126 
adjusted by the false discovery rate (FDR)-based method. Genes that met the selection criterion of fold 127 
change (FC) >1.5 were considered OVX-regulated. For statistical analysis of real-time PCR results we 128 
used one-way ANOVA. Pathway analysis was constructed by using the KEGG database; 129 
http://www.genome.jp/kegg). Putative protein-protein interactions were evaluated by the web-based 130 
STRING 10 platform (http://string-db.org), as reported previously (25). 131 
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 132 
Results 133 
Modification of hippocampal transcriptome in response to long-term OVX 134 
Microarray study 135 
The comparison of hippocampal transcriptomes from middle-aged intact (M) and middle-aged 136 
ovariectomized (M-OVX) rats revealed that chronic ablation of gonadal hormones by surgical OVX 137 
results in differential expression of genes. At FC > 1.5 criterion, more than 200 genes were differentially 138 
regulated. Downregulated genes (145) outnumbered upregulated (107) ones. The full list of genes is 139 
shown in Supplemental Table 1 providing the probe set ID, gene symbol and name, corresponding FC 140 
and adjusted P values. Top up- and downregulated genes selected at FC >1.7 are listed in Table 1. Top 141 
upregulated genes encode peptides like cocaine- and amphetamine-regulated transcript (Cartpt) and 142 
transthyretin (Ttr), peptidases (Sppl2a, Usp25,  Prcp), adhesion proteins (Vcl, Pcdh20), proteo- and 143 
glucosaminoglycans (Spock3, Fndc3a), ion channel (Trpm7), signaling molecule (Ptpn3) and 144 
transcription factors (Hif1a, Klf3) among others. In the top downregulated category, differentially 145 
regulated genes encode potassium channels (Kcnma1, Kcnj9, Kcnk9), serotonin receptor (Htr2c), 146 
neuropeptide (Adcyap1), members of G-protein coupled signaling mechanisms (Gpr123, Rgs17 and 147 
Rgs4), retinoid acid signaling molecule (Crabp1), components of growth factor signaling (Igfbp4, Nov), 148 
members of solute carrier family (Slc39a7, Slc17a6) and transcription factor (Etv1). 149 
Quantitative real-time PCR study  150 
In this study, the putative differential expression of 62 genes was examined by TaqMan-based PCR. 151 
Target selection was aimed at validation of the microarray result and also getting further insight to basic 152 
molecular mechanisms of neuronal networks of the hippocampus affected by OVX with special 153 
reference to synaptic plasticity, neurogenesis and immune modulation. The PCR results are listed in 154 
Table 2 and grouped in the aforementioned functional categories. In the clusters of synaptic plasticity 155 
and neurogenesis, both up- and downregulated genes were noted, on the other hand, most defense genes 156 
were upregulated. Neuropeptide and neurotransmitter signaling mechanisms shape neuronal plasticity 157 
of the hippocampal formation, accordingly, a large number of genes encoding various components of 158 
these signaling pathways were seen robustly changed by long-term OVX. In case of peptide signaling, 159 
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Cartpt, Ttr, Cck, Vip and Penk were involved. Altered expression of genes encoding neuropeptide 160 
receptors was revealed for Crh1r and Crh2r, Gnrhr, Cckbr, Sstr1 and Oprd1. Regarding the involvement 161 
of classic neurotransmitter signaling mechanisms, differential expression was found in case of 162 
cholinergic (Chrm4, Chrna3), glutamatergic (Grm8, Slc17a6), serotonergic (Htr2c) and histaminergic 163 
(Hrh3) systems. Neurogenesis in the subgranular layer of the hippocampal formation is highly regulated 164 
by growth and troph factors, and this process is mirrored in changes of transcriptional activity. OVX 165 
influences both mechanisms with a particular strong impact on growth/troph hormone signaling. To the 166 
most important contributors of this cluster belong nerve growth factor (Ngf, Ngfr, Ntf3, Ntrk), insulin-167 
like growth factor (Igf2, Igfbp4) and fibroblast growth factor (Fgf1) signaling systems. Regarding the 168 
regulation of transcription, Otx2 as classical transcription factor, whereas Esr1, Rxra and Thrb as ligand-169 
activated nuclear transcription factor genes responded to OVX. Alteration in the expression of Sgk1 170 
mRNA has extraordinary importance because of its wide-based regulatory potential. The gene cluster 171 
affiliated with processes of immune response and defense, covered predominantly upregulated genes 172 
like C3, Il1b, Tlr3, Tlr4, RT1-A1, Ccl2 and Aif1 among others. 173 
KEGG pathway analysis of OVX-regulated genes 174 
The top KEGG pathways changing in response to chronic OVX in middle-aged rats were summarized 175 
in Table 3. Neuroactive ligand-receptor interaction (ID: 4080, counts: 15), retrograde endocannabinoid 176 
signaling (ID: 4723, counts: 9), transcriptional misregulation in cancer (ID: 5202, counts 10), apoptosis 177 
(ID: 4210, counts: 7) and proteoglycans in cancer (ID: 5205, counts 11) pathways appeared at false 178 
discovery rate lesser than 0.005. Estrogen (ID: 4915) and thyroid (ID:4919) hormone signaling pathways 179 
also emerged. The influence on cholinergic (ID: 4725), glutamatergic (ID: 4724), adrenergic (ID: 4262) 180 
and serotonergic (ID: 4726) signaling pathways was also raised.  181 
Predicted networking of hippocampal proteins encoded by OVX-regulated genes 182 
In order to elucidate the interrelationship of genes, the predicted interaction and networking of proteins 183 
encoded by OVX-regulated changes were performed using the STRING 10 platform. The analysis was 184 
based on microarray and PCR results, carried out at confidence value 0.6. and the non-interacting genes 185 
were omitted. The networking of proteins coded by OVX-regulated genes is depicted in Supplementary 186 
Figure 1. Clusters of peptides serving neuropeptide and neurotransmitter signaling are explicit, similar 187 
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to protein assemblies regulating transcription. The OVX-regulated genes were sorted into up- and 188 
downregulated clusters (Tables 4 and 5) and the STRING analysis was implemented for both groups 189 
(Figure 1 and 2). Thirty-four upregulated, interacting proteins were sorted into 3 functional categories 190 
including growth/troph factors/transcription regulation, peptides/transmitters/ion channels/signaling 191 
and immune response/defense (Table 4). The downregulated group consisted of 47 proteins that were 192 
grouped in 4 operative categories such as  peptides/transmitters/receptors/ion channels/signaling, solute 193 
carriers, growth factors/transcription regulation and immune response/defense (Table 5).  194 
 195 
Discussion 196 
OVX modulates neurotransmission 197 
Modulation of peptidergic signaling  198 
Ablation of the ovaries affected interneurons of the hippocampal formation that responded mainly by 199 
downregulation of neuropeptide expression and also some of their genuine receptors. Cholecystokinin 200 
(Cck), neurotensin (Nts), vasoactive intestinal peptide (Vip) and preproenkephalin (Penk) are well-201 
established and characterized constituents of certain hippocampal interneurons (37-45). Cck exerts 202 
excitatory role on CA1 pyramidal neurons (46,47) via its B type receptor that was also altered after 203 
OVX. Vip also increases excitatory transmission to CA1 pyramidal neurons by disinhibition of their 204 
dendrites (48). Nts targets interneurons enhancing GABAergic activity by modulating L-type calcium 205 
channels (49). OVX influences the opioid peptide signal transduction in the hippocampus as exemplified 206 
by decreased expression genes encoding Penk and its cognate receptor Oprd1. Enkephalins are known 207 
to modify the activity of hippocampal circuits (50,51). Opioid inhibition of GABA release from terminal 208 
boutons of interneurons has previously been reported (52). These changes suggest that OVX modulates 209 
interneuron function via downregulation of neuropeptides resulting in declining excitatory transmission 210 
in the hippocampus. Adcyap1 (PACAP) derives from both interneurons and principal neurons of the 211 
hippocampal formation. It exerts effects on CA1 pyramidal neurons by inhibiting the slow after-212 
hyperpolarizing current (53). Increased PACAP level may also serve neurogenesis (54,55) and support 213 
neuroprotection (56,57). Accordingly, decreased Adcyap1 expression can affect the function of principal 214 
neurons, neurogenesis and protective mechanisms. Marked downregulation of Adcyap1 can’t be restored 215 
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by estradiol replacement (26). Decreased levels of type 1 and 2 CRH receptors indicate alteration in 216 
CRH signaling. Activation of these receptors has been reported to reduce the amplitude of hippocampal 217 
population spike and prevent the onset of long-term potentiation (LTP) (58). Downregulation of genes 218 
for CRHR subtypes decreases CRH-CRHR signaling and the impact of stress response on LTP. Estradiol 219 
replacement significantly increases Crhr2 expression. 220 
Regarding the upregulated category, the peptides CART, transthyretin, klotho and the Gnrhr were 221 
involved. The increase of CART and klotho seems to be advantageous for the hippocampus because of 222 
their renowned pro-cognitive effects (59,60). Increase in activation of Gnrhr may result in excitation of 223 
pyramidal neurons  (61,62) although data on the expression of its ligand GnRH are controversial (63,64). 224 
Estradiol replacement (26) and DPN administration (25) do not affect Cck, Nts and Vip, but activate 225 
Crhr2 and suppress Cart mRNA expression. 226 
Disturbances in neurotransmitter signaling 227 
In middle-aged rats, OVX affected transmitter signaling  via glutamate, acetylcholine, serotonin and 228 
histamine in the hippocampus, mainly by regulating the expression of their receptors (65). In case of 229 
glutamatergic signaling, Gria4, Grm1 and also Gls were upregulated, whereas Grm8 and Slc17a6 230 
downregulated. Grm1 and AMPA receptors occur in the hippocampus enriched in association with 231 
postsynaptic densities of neuronal elements communicating via synapses (66-69). Vesicular glutamate 232 
transporter 2 was reported to play a crucial role in the proper development of mature pyramidal neuronal 233 
architecture and plasticity, and in the processes of cognition (70). Striking decrease of Slc17a6 234 
expression affects glutamatergic signaling and cognition in the hippocampus after OVX. The signal 235 
transduction by serotonin is influenced via the downregulated Htr2c. Its activation regulates anxiety and 236 
release of acetylcholine in the hippocampus (71,72). Estradiol replacement and DPN administration 237 
restore Htr2c mRNA expression after OVX. Acetylcholine is a potent modulator of hippocampal circuits 238 
and has a pivotal role in cognition (73). Regarding the modulation of fast-synaptic neurotransmission, 239 
OVX influenced Chrna3. Its expression in the hippocampus has been reported earlier (74) and the 240 
present data indicate its downregulation. Similar to that, the expression of Chrm4 was also 241 
downregulated. Suppression of Chrm4 may affect synaptic transmission via alteration of glutamate 242 
release probability. Hippocampus-dependent memory and synaptic plasticity are modulated by the 243 
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estradiol milieu of the hippocampus (75-78). OVX also downregulated the expression of Hrh3. 244 
Antagonizing H3 receptor has been shown to increase the release of acetylcholine in the dorsal 245 
hippocampus and improve parameters of cognitive disorders (79). 246 
Vesicular monoamine transporter 2 (Vmat2) showed upregulation after OVX, an event that influences 247 
the transport of dopamine, epinephrine, norepinephrine, serotonin and histamine from the cytosol into 248 
synaptic vesicles of neurons and plays role in their vesicular release of transmitters by exocytosis. Mice 249 
mutant for Vmat2 display symptoms of depression (80). 250 
Modifications of potassium channels 251 
Effect of OVX was overwhelmingly manifested in altered expression of different potassium channels. 252 
The regulatory influence of estradiol has previously been described in case of slow Ca2+-activated K+ 253 
current and large-conductance, voltage- and calcium-activated potassium channels (81,82). The single 254 
upregulated gene was Kcnj6 that codes an ATP-sensitive, inwardly rectifying K+ channel that is 255 
regulated by G proteins and closed by the rise of intracellular ATP levels. Downregulated genes included 256 
Kcnj9, Kcnk9, Kcnma1 and Kcnc2. These alterations may lead to decreased synthesis of Kcnj9 (G 257 
protein-activated inward rectifier potassium channel 3) which regulates resting membrane potential and 258 
initiation of action potentials, Kcnk9 (Task 3 potassium channel) whose current is highly sensitive to 259 
changes in extracellular pH, Kcnma1 (BK, large conductance calcium-activated potassium channel) and 260 
Kcnc2 (Shaw-related K+ channel). Estrogenic regulation of BK (83) and G-protein-gated inwardly 261 
rectifying K+ (GIRK) (84) channels has previously been reported. The present results indicate that 262 
ablation of gonadal hormones in middle-aged rats changes the expression of all four functional types of 263 
potassium channels in the hippocampus (85) that depending on their cell type  and cellular domain 264 
specific expression can  modulate the excitability of hippocampal neurons. Long-term DPN treatment 265 
attenuates the decrease in Kcnma1 expression. 266 
OVX interferes with mechanisms involved in neurogenesis 267 
Influence on growth/troph hormone signaling 268 
OVX substantially influenced growth factor signaling within the hippocampus of middle-aged rats by 269 
dominantly upregulating the expression certain growth factors and their receptors. In the nerve growth 270 
factor family, Ntf3 and Ngf showed enhanced expression after OVX. In addition, two neurotrophin 271 
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receptor genes, Ngfr (coding for p75) and Ntrk1 (coding for TrkA) showed a similar, upregulated state. 272 
Neurotrophin signaling (86) has a key importance in neurogenesis and synaptic plasticity of the 273 
hippocampus (87-90). Two components of IGF signaling mechanisms were altered by OVX, the 274 
upregulated Igf2 and the downregulated Igfbp4. Igf2 is a potent regulator of neurogenesis (91) and it 275 
also controls memory consolidation and enhancement (92). The differentially expressed Fgf1 has been 276 
shown to support neuroprotective mechanisms (93) and facilitate LTP (94). Mdk, the retinoic acid-277 
responsive, heparin-binding growth factor gene also showed higher expression after gonadectomy. Mdk 278 
was reported to block kainic acid-induced seizure and concomitant cell death (95). We found slight 279 
upregulation of neutrophin and growth factor genes after OVX. In previous studies we demonstrated 280 
that estradiol and DPN increase further mRNA expression of many growth factor genes in the 281 
hippocampus of ovariectomized rats which may contribute to the enhanced neurogenesis after 282 
replacement (96). 283 
Impact on transcriptional regulation 284 
Orthodenticle homeobox 2 (Otx2) and hypoxia inducible factor 1 alpha subunit (Hif1a) were both 285 
upregulated by OVX. Otx2 shows altered expression in the hippocampus after tricyclic antidepressant 286 
treatment (97), whereas Hif1a responds to global ischemia (98). Aryl hydrocarbon receptor nuclear 287 
translocator 2 (Arnt2) was downregulated.  Its encoded protein complexes with Hif1a and the complex 288 
regulates oxygen-responsive genes. Members of the nuclear receptor superfamily were also influenced 289 
by OVX resulting in upregulation of Esr1 and Nr4a3 (neuron-derived orphan receptor 1). 290 
Downregulation characterized the expression of Thrb and Rxra. The changes suggest that ablation of 291 
ovarian hormone supply to the hippocampus interferes with estrogen, thyroid hormone and retinoic acid 292 
signaling mechanisms that are basic transcriptional regulators of diverse hippocampal functions 293 
(28,99,100). 294 
OVX affects defense mechanisms 295 
Modulation of the immune system 296 
We have previously reported the impact of OVX and treatment with ERα and ERβ specific agonists on 297 
the innate immune system of the hippocampal formation in middle aged rats (24). In accordance with 298 
that PCR study, here we confirm the differential expression of macrophage markers (Aif1, RT1-EC2), 299 
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phagocytic receptors (CD11b, Fcgr3a), recognition receptors (Tlr3, Tlr4), complement system (C3, Cfh) 300 
proinflammatory cytokine IL-1β (Il1b) and an IL3 receptor subunit (Il3ra). These upregulated genes 301 
reflect the sensitization of microglia and increased level of complement components leading to an 302 
increased proinflammatory stage in the absence of gonadal hormone signaling to the hippocampus. 303 
Chronic estradiol and DPN administrations attenuate OVX-dependent upregulation of microglia-related 304 
genes (24). In a recent study, the role NLRP3 inflammasome activation was shown in development of 305 
estrogen deficiency-related affective disorders (101). 306 
Effects on neuroprotective mechanisms 307 
Long-term OVX decreased the expression of genes encoding Bcl-2 (Bcl2) and superoxide dismutase 308 
(Sod1). These events are known to lead to increased apoptotic activity and enhanced level of the reactive 309 
superoxide radical, O2-. The neuroprotective role of Bcl-2 and Sod1 in the hippocampal circuits has been 310 
widely explored (102-107). Decreased synthesis of synuclein beta after OVX may promote alpha 311 
synuclein accumulation and trigger neurodegeneration (108,109). Estradiol replacement (26) and long-312 
term DPN treatment (25) activate transcription of genes involved in protection against oxidative stress 313 
and detoxification such as Sod3, Gpx1, Gstm2, Gsta4, but do not increase Bcl2 and Sod1 expression in 314 
the hippocampus. 315 
 316 
To sum up, the present study demonstrated extensive transcriptional changes in the hippocampus after 317 
OVX in middle-aged rats. Ablation of the ovarian hormone supply influences the machinery of 318 
transcription, growth factor signaling, channels of synaptic communication, immune and 319 
neuroprotective mechanisms modulating neurogenesis, synaptic plasticity and immunomodulation. 320 
Some but not all changes can be restored by estradiol replacement.  Regarding the translational value, 321 
the results suggest the careful consideration and risk evaluation of the effects of oophorectomy (and 322 
menopause) on basic neuronal operation and cognitive performance of the hippocampus in middle-aged 323 
individuals (110-112).   324 
  325 
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Table 1.    List of top hippocampal genes regulated by long-term OVX in middle-aged rats 658 
 659 
Probeset ID logFC FC adj. P Symbol Description
1394252_PM_at 1.194 2.288 0.356 Spock3 sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3
1368585_PM_at 1.188 2.278 0.141 Cartpt CART prepropeptide
1391387_PM_s_at 1.158 2.232 0.479 Slbp stem-loop binding protein
1391208_PM_at 1.087 2.124 0.178 Pcdh20 protocadherin 20
1380805_PM_at 1.060 2.084 0.310 Pvrl3 poliovirus receptor-related 3
1393247_PM_at 0.974 1.965 0.462 Zfp26 zinc finger protein 26
1378679_PM_at 0.963 1.949 0.446 Usp25 ubiquitin specific peptidase 25
1390812_PM_a_at 0.961 1.947 0.159 Rerg RAS-like, estrogen-regulated, growth-inhibitor
1398355_PM_at 0.950 1.931 0.456 Trpm7 transient receptor potential cation channel, subfamily M, 7
1380279_PM_at 0.934 1.911 0.410 Prcp prolylcarboxypeptidase (angiotensinase C)
1383396_PM_at 0.929 1.904 0.460 Fndc3a fibronectin type III domain containing 3a
1375676_PM_at 0.915 1.886 0.460 Lin7c lin-7 homolog C (C. elegans )
1374959_PM_at 0.894 1.858 0.457 Nqo2 NAD(P)H dehydrogenase, quinone 2
1389479_PM_at 0.890 1.853 0.419 Klf3 Kruppel-like factor 3 (basic)
1395744_PM_at 0.886 1.849 0.477 Sppl2a signal peptide peptidase-like 2A
1389362_PM_at 0.856 1.811 0.246 Ptpn3 protein tyrosine phosphatase, non-receptor type 3
1382171_PM_at 0.851 1.804 0.515 Tsc22d2 TSC22 domain family, member 2
1387076_PM_at 0.850 1.802 0.460 Hif1a hypoxia-inducible factor 1, alpha subunit 
1375538_PM_at 0.835 1.784 0.519 Vcl vinculin
1376319_PM_at 0.834 1.783 0.061 Sema3c semaphorin 3C
1382390_PM_at 0.809 1.752 0.469 Fubp3 far upstream element (FUSE) binding protein 3
1367598_PM_at 0.793 1.733 0.616 Ttr transthyretin
1372905_PM_at 0.782 1.720 0.530 Vcl vinculin
1377651_PM_at 0.774 1.710 0.445 Trio triple functional domain (PTPRF interacting)
1370472_PM_a_at -0.802 0.574 0.445 Kcnma1 K large conductance Ca-activated channel, subfamily M, α 1
1391074_PM_at -0.807 0.572 0.440 Crabp1 cellular retinoic acid binding protein 1
1367768_PM_at -0.807 0.572 0.222 Lxn latexin
1383386_PM_a_at -0.814 0.569 0.463 Sec3l1 SEC3-like 1 (S. cerevisiae )
1391075_PM_at -0.817 0.568 0.341 Rgs17 regulator of G-protein signaling 17
1392823_PM_at -0.818 0.567 0.419 Snhg11 small nucleolar RNA host gene 11 (non-protein coding)
1369418_PM_at -0.828 0.563 0.419 Kcnj9 potassium inwardly-rectifying channel, subfamily J, member 9
1369280_PM_at -0.833 0.561 0.326 Kcnk9 potassium channel, subfamily K, member 9
1387291_PM_at -0.861 0.551 0.123 Itih3 inter-alpha trypsin inhibitor, heavy chain 3
1379481_PM_at -0.863 0.550 0.460 Pabpn1 poly(A) binding protein, nuclear 1
1370248_PM_at -0.873 0.546 0.159 Fxyd6 FXYD domain-containing ion transport regulator 6
1371132_PM_a_at -0.875 0.545 0.459 Ank3 ankyrin 3, node of Ranvier
1389089_PM_at -0.887 0.541 0.479 Slc39a7 solute carrier family 39 (zinc transporter), member 7
1386940_PM_at -0.911 0.532 0.419 Timp2 TIMP metallopeptidase inhibitor 2
1379046_PM_at -0.920 0.528 0.479 Mlec malectin
1398303_PM_s_at -0.948 0.518 0.459 Tpm3 tropomyosin 3, gamma
1368883_PM_at -0.969 0.511 0.184 Nov nephroblastoma overexpressed gene
1376980_PM_at -0.973 0.510 0.222 Htr2c 5-hydroxytryptamine (serotonin) receptor 2C
1392555_PM_at -1.029 0.490 0.166 Etv1 ets variant 1
1397513_PM_at -1.045 0.485 0.431 Ralyl RALY RNA binding protein-like
1371462_PM_at -1.054 0.482 0.103 Igfbp4 insulin-like growth factor binding protein 4
1373257_PM_at -1.068 0.477 0.419 Arpp21 cAMP-regulated phosphoprotein 21
1389155_PM_at -1.081 0.473 0.393 Dos downstream of Stk11
1368381_PM_at -1.095 0.468 0.439 Crtac1 cartilage acidic protein 1
1384809_PM_at -1.119 0.460 0.026 Gpr123 G protein-coupled receptor 123
1390865_PM_at -1.121 0.460 0.026 Cadps2 Ca++-dependent secretion activator 2
1385491_PM_at -1.143 0.453 0.299 Pnmal2 PNMA-like 2
1370602_PM_at -1.301 0.406 0.159 Atp2b4 ATPase, Ca++ transporting, plasma membrane 4
1385788_PM_at -1.479 0.359 0.419 Ephb3 Eph receptor B3
1368564_PM_at -1.482 0.358 0.133 Slc17a6 sodium-dependent inorganic phosphate cotransporter
1368892_PM_at -1.654 0.318 0.026 Adcyap1 adenylate cyclase activating polypeptide 1
1368505_PM_at -1.868 0.274 0.032 Rgs4 regulator of G-protein signaling 4
Upregulated Genes
Downregulated Genes
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Expression profiling by Affymetrix oligonucleotide microarray revealed that long-term OVX intensely 660 
regulates the hippocampal transcriptome in middle-aged rats. Using the FC >1.7 selection criterion, the 661 
top list contains 24 up- and 32 downregulated genes. 662 
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Table 2.    PCR results 664 
 665 
Assay ID Symbol Target name RQ P value
Rn01645174_m1 Cartpt CART propeptide 2.598 0.003
Rn00562124_m1 Ttr transthyretin 2.251 0.097
Rn00564688_m1 Slc18a2 vesicular monoamine transporter 2 1.645 0.001
Rn00578981_m1 Gnrhr gonadotropin releasing hormone receptor 1.631 0.004
Rn01454304_m1 Dagla diacylglycerol lipase alpha 1.387 0.013
Rn00582505_m1 Slc12a2 Na-K-Cl cotransporter 1.386 0.094
Rn03993699_s1 Cnr2 cannabinoid receptor 2 1.250 0.070
Rn01505088_m1 Enpp2 ectonucleotide phosphodiesterase 2 1.221 0.015
Rn01234233_m1 Kcnc2 voltage-gated potassium channel 0.861 0.058
Rn00563215_m1 Cck cholecystokinin 0.821 0.007
Rn01512605_s1 Chrm4 cholinergic receptor, muscarinic 4 0.775 0.031
Rn00578611_m1 Crhr1 corticotropin releasing hormone receptor 1 0.766 0.063
Rn00565867_m1 Cckbr cholecystokinin B receptor 0.748 0.111
Rn01430567_m1 Vip vasoactive intestinal peptide 0.733 0.001
Rn00561699_m1 Oprd1 delta 1 opioid receptor 0.723 0.051
Rn00585276_m1 Hrh3 histamine receptor H3 0.686 0.000
Rn00575617_m1 Crhr2 corticotropin releasing hormone receptor 2 0.650 0.016
Rn00567566_m1 Penk preproenkephalin 0.644 0.000
Rn01456072_m1 Cadps2 Ca-dependent activator protein for secretion 0.599 0.001
Rn02532012_s1 Sstr1 somatostatin receptor 1 0.382 0.001
Rn00562748_m1 Htr2c 5HT receptor 2C 0.363 0.000
Rn00573505_m1 Grm8 glutamate metabotropic receptor 8 0.357 0.001
Rn00584780_m1 Slc17a6 vesicular glutamate transporter 2 0.260 0.000
Rn00583820_m1 Chrna3 cholinergic receptor nicotinic alpha 3 subunit 0.214 0.001
Rn01414596_m1 Otx2 orthodenticle homeobox 2 4.934 0.014
Rn00591759_m1 Folr1 folate receptor 1 2.360 0.004
Rn00580123_m1 Kl klotho 2.104 0.094
Rn00572130_m1 Ntrk1 neurotrophic receptor tyrosine kinase 1 1.870 0.069
Rn01754856_m1 Ucp2 uncoupling protein 2 1.548 0.002
Rn00561634_m1 Ngfr nerve growth factor receptor 1.506 0.008
Rn00579280_m1 Ntf3 neurotrophin 3 1.491 0.003
Rn01640372_m1 Esr1 estrogen receptor alpha 1.422 0.030
Rn01427989_s1 Cdkn1a cyclin-dependent kinase inhibitor 1A 1.404 0.002
Rn00675549_g1 Mdk midkine 1.355 0.054
Rn01533872_m1 Ngf nerve growth factor 1.306 0.023
Rn00689153_m1 Fgf1 fibroblast growth factor 1 1.278 0.039
Rn01537468_g1 Sgk1 serum- glucocorticoid-regulated kinase 1 1.257 0.018
Rn01454518_m1 Igf2 insulin-like growth factor 2 1.160 0.109
Rn00578713_m1 Adcy2 adenylate cyclase 2 0.881 0.004
Rn00575368_m1 Fkbp1b FK506 binding protein 1B 0.863 0.017
Rn00441185_m1 Rxra retinoid X receptor alpha 0.852 0.068
Rn00567957_m1 Map6 microtubule-associated protein 6 0.814 0.020
Rn99999125_m1 Bcl2 B-cell lymphoma 2 0.780 0.001
Rn00562044_m1 Thrb thyroid hormone receptor beta 0.777 0.008
Rn00578390_m1 Nov nephroblastoma overexpressed 0.732 0.001
Rn01464112_m1 Igfbp4 insulin-like growth factor binding protein 4 0.480 0.001
Rn00566438_m1 Adcyap1 adenylate cyclase activating polypeptide 1 0.411 0.001
Rn01483363_m1 Atp2b4 ATPase plasma membrane Ca transporting 4 0.361 0.000
Rn00566938_m1 Sod1 superoxide dismutase 1 0.284 0.001
Rn01490867_g1 Rgs4 regulator of G protein signaling 4 0.272 0.000
Rn03034964_u1 RT1-EC2 RT1-EC2 2.121 0.012
Rn00580555_m1 Ccl2 C-C motif chemokine ligand 2 1.930 0.010
Rn00566466_m1 C3 complement C3 1.750 0.001
Rn01488472_g1 Tlr3 toll-like receptor 3 1.663 0.006
Rn00709342_m1 Itgam Cd11b 1.639 0.005
Rn00580432_m1 Il1b interleukin 1beta 1.437 0.114
Rn00560589_m1 A2m alpha-2-macroglobulin 1.330 0.001
Rn00564605_m1 Ptgds prostaglandin D2 synthase 1.253 0.039
Rn01483598_m1 Fcgr3a Fc gamma receptor 3a 1.245 0.058
Rn00574125_g1 Aif1 allograft inflammatory factor 1 1.207 0.036
Rn00569848_m1 Tlr4 toll-like receptor 4 1.197 0.028
Rn00563082_m1 Mfge8 milk fat globule-EGF factor 8 protein 0.777 0.001
Neurotransmitter and neuropeptide signaling/ Synaptic plasticity
Growth and troph factor signaling/ Neurogenesis
Immune modulation/ Defense
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Real-time PCR study revealed transcriptional regulation of 62 genes. Thirty-three of them were 666 
upregulated. The OVX-regulated genes were grouped in three functional clusters:  neurotransmitter and 667 
neuropeptide signaling/ synaptic plasticity, growth and troph factor signaling/ neurogenesis, immune 668 
modulation/ defense. RQ, relative quantity.  669 
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Table 3.    Pathway analysis 671 
 672 
Top gene ontology pathways affected by OVX in middle-aged rats. The analysis was performed on the 673 
web-based KEGG platform. Terms were ranked based on their FDR values. FDR, false discovery rate. 674 
  675 
Pathway ID Pathway description Count FDR
4080 Neuroactive ligand-receptor interaction 15 0.0007
4723 Retrograde endocannabinoid signaling 9 0.0007
5202 Transcriptional misregulation in cancer 10 0.0032
4210 Apoptosis 7 0.0057
5205 Proteoglycans in cancer 11 0.0072
4915 Estrogen signaling pathway 7 0.0075
4725 Cholinergic synapse 7 0.0111
4750 Inflammatory mediator regulation of TRP channels 7 0.0111
4724 Glutamatergic synapse 7 0.0134
4919 Thyroid hormone signaling pathway 7 0.0170
5200 Pathways in cancer 12 0.0204
4810 Regulation of actin cytoskeleton 9 0.0328
4261 Adrenergic signaling in cardiomyocytes 7 0.0379
4921 Oxytocin signaling pathway 7 0.0419
4726 Serotonergic synapse 6 0.0480
KEGG Pathways
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Table 4.    Functional clusters of upregulated genes in OVX, middle-aged rats  676 
 677 
Symbol Gene name FC
Esr1 estrogen receptor alpha 1.422
Fgf1 fibroblast growth factor 1 1.278
Hif1a hypoxia-inducible factor 1, alpha subunit 1.802
Igf2 insulin-like growth factor 2 1.160
Mdk midkine 1.355
Ngf nerve growth factor 1.306
Ngfr nerve growth factor receptor 1.506
Ntrk1 neurotrophic tyrosine kinase, receptor, type 1 1.520
Ntf3 neurotrophin 3 1.491
Nr4a3 nuclear receptor subfamily 4, group A, member 3 1.522
Otx2 orthodenticle homeobox 2 4.934
Rerg RAS-like, estrogen-regulated, growth-inhibitor 1.947
Cartpt CART prepropeptide 2.278
Gria4 glutamate receptor, ionotrophic, AMPA 4 1.506
Grm1 glutamate receptor, metabotropic 1 1.532
Gls glutaminase 1.580
Gnrhr gonadotropin releasing hormone receptor 1.631
Kcnj6 K inwardly-rectifying channel, subfamily J, 6 1.517
Kl klotho 2.104
Slc12a2 Na-K-Cl cotransporter 1.386
Ttr transthyretin 2.251
Slc18a2 vesicular monoamine transporter 2 1.645
Aif1 allograft inflammatory factor 1 1.207
A2m alpha-2-macroglobulin 1.330
Ccl2 C-C motif chemokine ligand 2 1.930
C3 complement C3 1.750
Itgam Cd11b 1.639
Cfh complement factor H 1.551
Fcgr3a Fc gamma receptor 3a 1.245
Il1b interleukin 1beta 1.437
RT1-EC2 RT1-EC2 2.121
Sep7 septin 7 1.545
Tlr3 toll-like receptor 3 1.663
Tlr4 toll-like receptor 4 1.197
Functional gene clusters upregulated by OVX
Growth/troph factors/transcription regulation
Peptides/transmitters/ion channels/signaling
Immune response/defense
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Representative upregulated genes grouped in three functional clusters as growth/troph factors/ 678 
transcriptional regulation, peptides/transmitters/ion channels/signaling and immune response/ defense. 679 
FC in italics refers to PCR results. FC, fold change. 680 
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Table 5.    Functional clusters of downregulated genes in OVX, middle-aged rats 682 
 683 
Symbol Gene name FC
Htr2c 5HT receptor 2C 0.363
Adcy2 adenylate cyclase 2 0.881
Adcyap1 adenylate cyclase activating polypeptide 1 0.411
Crebl2 cAMP responsive element binding protein-like 2 0.604
Cbln2 cerebellin 2 precursor 0.613
Cck cholecystokinin 0.821
Cckbr cholecystokinin B receptor 0.748
Chrna3 cholinergic receptor nicotinic alpha 3 subunit 0.214
Chrm4 cholinergic receptor, muscarinic 4 0.775
Crhr1 corticotropin releasing hormone receptor 1 0.766
Crhr2 corticotropin releasing hormone receptor 2 0.650
Oprd1 delta 1 opioid receptor 0.723
Grm8 glutamate metabotropic receptor 8 0.357
Hrh3 histamine receptor H3 0.686
Kcnk9 K channel, subfamily K, member 9 0.561
Kcnj9 K inwardly-rectifying channel, subfamily J, 9 0.563
Kcnma1 K large conductance Ca-activated channel, subfamily M 0.574
Nts neurotensin 0.653
Penk preproenkephalin 0.644
Rgs4 regulator of G protein signaling 4 0.272
Rgs17 regulator of G-protein signaling 17 0.568
Sstr1 somatostatin receptor 1 0.382
Vip vasoactive intestinal peptide 0.733
Slc17a6 vesicular glutamate transporter 2 0.260
Vdac1 voltage-dependent anion channel 1 0.641
Kcnc2 voltage-gated potassium channel 0.861
Slc1a4 solute carrier family 1, member 4 0.657
Slc10a4 solute carrier family 10, member 4 0.638
Slc17a6 solute carrier family 17, member 6 0.358
Slc25a18 solute carrier family 25, member 18 0.646
Slc39a7 solute carrier family 39, member 7 0.541
Slc4a3 solute carrier family 4, member 3 0.653
Slc6a17 solute carrier family 6, member 17 0.623
Slc9a1 solute carrier family 9, member 1 0.631
Slc9a5 solute carrier family 9, member 5 0.648
Arnt2 aryl hydrocarbon receptor nuclear translocator 2 0.657
Crabp1 cellular retinoic acid binding protein 1 0.572
Hsp90ab1 heat shock protein 90 alpha (cytosolic), class B member 1 0.646
Igfbp4 insulin-like growth factor binding protein 4 0.480
Rxra retinoid X receptor alpha 0.852
Thrb thyroid hormone receptor beta 0.777
Apitd1 apoptosis-inducing, TAF9-like domain 1 0.643
Bcl2 B-cell lymphoma 2 0.780
C1ql3 complement component 1, q subcomponent-like 3 0.646
Il3ra interleukin 3 receptor, alpha 0.661
Sod1 superoxide dismutase 1 0.284
Sncb synuclein, beta 0.614
Functional gene clusters downregulated by OVX
Peptides/transmitters/receptors/ion channels/signaling
Solute carriers
Growth factor/transcription regulation
Immune response/defense
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Representative downregulated genes assembled in four functional clusters as 684 
peptides/transmitters/receptors/ion channels/signaling, solute carriers, growth factor/transcription 685 
regulation and immune response/defense. FC in italics refers to PCR results. FC, fold change. 686 
  687 
 29 
Figure legends 688 
 689 
Figure 1.  Predicted interactions among proteins encoded by upregulated genes in long-term 690 
ovariectomized, middle aged rats.  The network is based on combined results of microarray and 691 
quantitative real-time PCR studies and was constructed by using the STRING 10 Known and Predicted 692 
Protein-Protein Interactions program (http://string-db.org/). Analysis was performed at confidence value 693 
0.6 and non-interacting elements were excluded. Selected protein clusters of the network are shown by 694 
color frames. The red box marks growth factor signaling, blue identifies immune response, yellow 695 
indicates peptide and transmitter signaling, green marks regulation of transcription. 696 
Figure 2.  Predicted interactions among proteins encoded by downregulated genes in long-697 
term ovariectomized, middle aged rats.  The network is based on combined results of microarray and 698 
quantitative real-time PCR studies and was constructed by using the STRING 10 Known and Predicted 699 
Protein-Protein Interactions program (http://string-db.org/). Analysis was performed at confidence value 700 
0.6 and non-interacting elements were excluded. Selected protein clusters of the network are shown by 701 
color frames. The red box marks peptide and transmitter signaling, blue indicates potassium channels, 702 
orange marks transcriptional regulation, green identifies heterogeneous nuclear ribonucleoproteins. 703 
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Figure 1 705 
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Figure 2 707 
 708 
